Cargando…
Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report
BACKGROUND: Arthrogryposis-Renal dysfunction-Cholestasis syndrome (ARC, MIM#208085) is a rare multisystem disease due to mutations in the VPS33B and VIPAR genes, both involved in maintaining apical-basolateral cell polarity. The correlation between mutations and phenotype in the ARC Syndrome is not...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003143/ https://www.ncbi.nlm.nih.gov/pubmed/29907094 http://dx.doi.org/10.1186/s12882-018-0926-1 |
_version_ | 1783332316589850624 |
---|---|
author | Rosales, Alejandra Mhibik, Maissa Gissen, Paul Segarra, Oscar Redecillas, Susana Ariceta, Gema |
author_facet | Rosales, Alejandra Mhibik, Maissa Gissen, Paul Segarra, Oscar Redecillas, Susana Ariceta, Gema |
author_sort | Rosales, Alejandra |
collection | PubMed |
description | BACKGROUND: Arthrogryposis-Renal dysfunction-Cholestasis syndrome (ARC, MIM#208085) is a rare multisystem disease due to mutations in the VPS33B and VIPAR genes, both involved in maintaining apical-basolateral cell polarity. The correlation between mutations and phenotype in the ARC Syndrome is not well described. We report on a 6 year old patient who presented with severe renal Fanconi as first manifestation of ARC related to a combined de novo mutation in the VPS33B gene. CASE PRESENTATION: A 6 year old girl presented during the first year of life with severe renal Fanconi as the first manifestation of ARC-Syndrome. This case presents all defining features of ARC syndrome (including liver, skin and articular manifestations) with predominantly renal impairment at presentation. This novel mutation may be associated with a pronounced renal phenotype in ARC. Furthermore, we report on the successful use of LDL-Apheresis and biliodigestive derivation for treatment of cholestatic pruritus with encouraging results. CONCLUSION: ARC is a heterogeneous disorder with early mortality. This case report contributes to a better understanding of this rare disorder, describes a novel mutation in the VPS33B gene and presents an innovative rescue treatment approach. |
format | Online Article Text |
id | pubmed-6003143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60031432018-07-06 Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report Rosales, Alejandra Mhibik, Maissa Gissen, Paul Segarra, Oscar Redecillas, Susana Ariceta, Gema BMC Nephrol Case Report BACKGROUND: Arthrogryposis-Renal dysfunction-Cholestasis syndrome (ARC, MIM#208085) is a rare multisystem disease due to mutations in the VPS33B and VIPAR genes, both involved in maintaining apical-basolateral cell polarity. The correlation between mutations and phenotype in the ARC Syndrome is not well described. We report on a 6 year old patient who presented with severe renal Fanconi as first manifestation of ARC related to a combined de novo mutation in the VPS33B gene. CASE PRESENTATION: A 6 year old girl presented during the first year of life with severe renal Fanconi as the first manifestation of ARC-Syndrome. This case presents all defining features of ARC syndrome (including liver, skin and articular manifestations) with predominantly renal impairment at presentation. This novel mutation may be associated with a pronounced renal phenotype in ARC. Furthermore, we report on the successful use of LDL-Apheresis and biliodigestive derivation for treatment of cholestatic pruritus with encouraging results. CONCLUSION: ARC is a heterogeneous disorder with early mortality. This case report contributes to a better understanding of this rare disorder, describes a novel mutation in the VPS33B gene and presents an innovative rescue treatment approach. BioMed Central 2018-06-15 /pmc/articles/PMC6003143/ /pubmed/29907094 http://dx.doi.org/10.1186/s12882-018-0926-1 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Rosales, Alejandra Mhibik, Maissa Gissen, Paul Segarra, Oscar Redecillas, Susana Ariceta, Gema Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report |
title | Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report |
title_full | Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report |
title_fullStr | Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report |
title_full_unstemmed | Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report |
title_short | Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report |
title_sort | severe renal fanconi and management strategies in arthrogryposis-renal dysfunction-cholestasis syndrome: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003143/ https://www.ncbi.nlm.nih.gov/pubmed/29907094 http://dx.doi.org/10.1186/s12882-018-0926-1 |
work_keys_str_mv | AT rosalesalejandra severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport AT mhibikmaissa severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport AT gissenpaul severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport AT segarraoscar severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport AT redecillassusana severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport AT aricetagema severerenalfanconiandmanagementstrategiesinarthrogryposisrenaldysfunctioncholestasissyndromeacasereport |